• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心房颤动:一级预防、二级预防及血栓栓塞并发症的预防:第1部分

Atrial fibrillation: primary prevention, secondary prevention, and prevention of thromboembolic complications: part 1.

作者信息

Trohman Richard G, Huang Henry D, Sharma Parikshit S

机构信息

Section of Electrophysiology, Division of Cardiology, Department of Internal Medicine, Rush University Medical Center, Chicago, IL, United States.

出版信息

Front Cardiovasc Med. 2023 Jun 15;10:1060030. doi: 10.3389/fcvm.2023.1060030. eCollection 2023.

DOI:10.3389/fcvm.2023.1060030
PMID:37396596
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10311453/
Abstract

Atrial fibrillation (AF), is the most common sustained cardiac arrhythmia. It was once thought to be benign as long as the ventricular rate was controlled, however, AF is associated with significant cardiac morbidity and mortality. Increasing life expectancy driven by improved health care and decreased fertility rates has, in most of the world, resulted in the population aged ≥65 years growing more rapidly than the overall population. As the population ages, projections suggest that the burden of AF may increase more than 60% by 2050. Although considerable progress has been made in the treatment and management of AF, primary prevention, secondary prevention, and prevention of thromboembolic complications remain a work in progress. This narrative review was facilitated by a MEDLINE search to identify peer-reviewed clinical trials, randomized controlled trials, meta-analyses, and other clinically relevant studies. The search was limited to English-language reports published between 1950 and 2021. Google and Google scholar as well as bibliographies of identified articles were reviewed for additional references. In these two manuscripts, we discuss the current strategies available to prevent AF, then compare noninvasive and invasive treatment strategies to diminish AF recurrence. In addition, we examine the pharmacological, percutaneous device and surgical approaches to prevent stroke as well as other types of thromboembolic events.

摘要

心房颤动(AF)是最常见的持续性心律失常。它曾被认为只要心室率得到控制就是良性的,然而,AF与显著的心脏发病率和死亡率相关。在世界上大多数地区,医疗保健改善和生育率下降导致预期寿命增加,使得65岁及以上人口的增长速度超过了总人口。随着人口老龄化,预测表明到2050年AF的负担可能增加60%以上。尽管在AF的治疗和管理方面已经取得了相当大的进展,但一级预防、二级预防以及血栓栓塞并发症的预防仍在进行中。本叙述性综述通过MEDLINE检索来确定同行评审的临床试验、随机对照试验、荟萃分析和其他临床相关研究。检索仅限于1950年至2021年发表的英文报告。还查阅了谷歌和谷歌学术以及已识别文章的参考文献列表以获取更多参考文献。在这两篇手稿中,我们讨论了目前可用于预防AF的策略,然后比较了减少AF复发的非侵入性和侵入性治疗策略。此外,我们研究了预防中风以及其他类型血栓栓塞事件的药物、经皮装置和手术方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cf0/10311453/c14ccb94ee12/fcvm-10-1060030-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cf0/10311453/76e7d987c918/fcvm-10-1060030-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cf0/10311453/f431380abfdc/fcvm-10-1060030-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cf0/10311453/7c43094c0c30/fcvm-10-1060030-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cf0/10311453/2d28c18365c3/fcvm-10-1060030-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cf0/10311453/52270384fd4d/fcvm-10-1060030-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cf0/10311453/0974821eb372/fcvm-10-1060030-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cf0/10311453/c14ccb94ee12/fcvm-10-1060030-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cf0/10311453/76e7d987c918/fcvm-10-1060030-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cf0/10311453/f431380abfdc/fcvm-10-1060030-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cf0/10311453/7c43094c0c30/fcvm-10-1060030-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cf0/10311453/2d28c18365c3/fcvm-10-1060030-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cf0/10311453/52270384fd4d/fcvm-10-1060030-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cf0/10311453/0974821eb372/fcvm-10-1060030-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cf0/10311453/c14ccb94ee12/fcvm-10-1060030-g007.jpg

相似文献

1
Atrial fibrillation: primary prevention, secondary prevention, and prevention of thromboembolic complications: part 1.心房颤动:一级预防、二级预防及血栓栓塞并发症的预防:第1部分
Front Cardiovasc Med. 2023 Jun 15;10:1060030. doi: 10.3389/fcvm.2023.1060030. eCollection 2023.
2
Atrial fibrillation: Primary prevention, secondary prevention, and prevention of thromboembolic complications: Part 2.心房颤动:一级预防、二级预防及血栓栓塞并发症的预防:第2部分
Front Cardiovasc Med. 2023 Mar 10;9:1060096. doi: 10.3389/fcvm.2022.1060096. eCollection 2022.
3
Narrative Review: Surgical and Hybrid Management of Atrial Fibrillation.叙述性综述:心房颤动的手术及综合治疗
Cardiol Ther. 2024 Sep;13(3):493-528. doi: 10.1007/s40119-024-00377-2. Epub 2024 Aug 12.
4
Ablation for atrial fibrillation: an evidence-based analysis.心房颤动的消融治疗:基于证据的分析。
Ont Health Technol Assess Ser. 2006;6(7):1-63. Epub 2006 Mar 1.
5
Advanced electrophysiologic mapping systems: an evidence-based analysis.先进的电生理标测系统:基于证据的分析
Ont Health Technol Assess Ser. 2006;6(8):1-101. Epub 2006 Mar 1.
6
Catheter ablation in combination with left atrial appendage closure for atrial fibrillation.导管消融联合左心耳封堵治疗心房颤动
J Vis Exp. 2013 Feb 26(72):e3818. doi: 10.3791/3818.
7
Interrupted versus uninterrupted anticoagulation therapy for catheter ablation in adults with arrhythmias.心律失常成人患者行导管消融术时,中断与不中断抗凝治疗的比较。
Cochrane Database Syst Rev. 2021 Oct 21;10(10):CD013504. doi: 10.1002/14651858.CD013504.pub2.
8
Incidence of thromboembolic events following atrial fibrillation catheter ablation and rate control strategies according to the kind of oral anticoagulation: A systematic review and meta-analysis.根据口服抗凝药物的种类,心房颤动导管消融和心率控制策略后血栓栓塞事件的发生率:系统评价和荟萃分析。
Int J Cardiol. 2018 Nov 1;270:172-179. doi: 10.1016/j.ijcard.2018.06.082. Epub 2018 Jun 19.
9
Can catheter ablation reduce the incidence of thromboembolic events in patients with atrial fibrillation?: Protocol for a systematic review and meta-analysis.导管消融能否降低房颤患者血栓栓塞事件的发生率?:一项系统评价与荟萃分析方案
Medicine (Baltimore). 2017 Dec;96(48):e8479. doi: 10.1097/MD.0000000000008479.
10
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.

引用本文的文献

1
Extremely elevated high-density lipoprotein cholesterol and the risk of atrial fibrillation: the Suita Study.极高密度脂蛋白胆固醇与心房颤动风险:吹田研究
J Epidemiol. 2025 May 17;35(9):420-2. doi: 10.2188/jea.JE20240428.
2
Characterization and anticoagulation treatment patterns of hospitalized patients with nonvalvular atrial fibrillation in Spain: The CARISMA registry.西班牙非瓣膜性心房颤动住院患者的特征及抗凝治疗模式:CARISMA注册研究
Int J Cardiol Heart Vasc. 2025 Mar 1;57:101639. doi: 10.1016/j.ijcha.2025.101639. eCollection 2025 Apr.
3
Narrative Review: Surgical and Hybrid Management of Atrial Fibrillation.

本文引用的文献

1
Population-Level Analyses of Alcohol Consumption as a Predictor of Acute Atrial Fibrillation Episodes.饮酒作为急性房颤发作预测因素的人群水平分析
Nat Cardiovasc Res. 2022 Jan;1(1):23-27. doi: 10.1038/s44161-021-00003-7. Epub 2022 Jan 12.
2
Effect of High-Intensity Interval Training in Patients With Atrial Fibrillation: A Randomized Clinical Trial.高强度间歇训练对心房颤动患者的影响:一项随机临床试验。
JAMA Netw Open. 2022 Oct 3;5(10):e2239380. doi: 10.1001/jamanetworkopen.2022.39380.
3
Effect of continuous positive airway pressure therapy on recurrence of atrial fibrillation after pulmonary vein isolation in patients with obstructive sleep apnea: A randomized controlled trial.
叙述性综述:心房颤动的手术及综合治疗
Cardiol Ther. 2024 Sep;13(3):493-528. doi: 10.1007/s40119-024-00377-2. Epub 2024 Aug 12.
4
Longitudinal Analysis of Predictive Factors for Stroke and Bleeding Events in Atrial Fibrillation Patients: Insights From a Tertiary Care Center Cohort.心房颤动患者中风和出血事件预测因素的纵向分析:来自三级医疗中心队列的见解
Cureus. 2024 May 2;16(5):e59519. doi: 10.7759/cureus.59519. eCollection 2024 May.
5
The application and mechanism of Chinese medicine in the upstream treatment of atrial fibrillation.中医药在心房颤动上游治疗中的应用及机制
Front Cardiovasc Med. 2023 Aug 7;10:1229021. doi: 10.3389/fcvm.2023.1229021. eCollection 2023.
持续气道正压通气治疗对阻塞性睡眠呼吸暂停患者肺静脉隔离术后心房颤动复发的影响:一项随机对照试验。
Heart Rhythm. 2022 Sep;19(9):1433-1441. doi: 10.1016/j.hrthm.2022.06.016. Epub 2022 Jun 16.
4
The Increasing Role of Rhythm Control in Patients With Atrial Fibrillation: JACC State-of-the-Art Review.心房颤动患者节律控制作用的增加:JACC 现状述评。
J Am Coll Cardiol. 2022 May 17;79(19):1932-1948. doi: 10.1016/j.jacc.2022.03.337.
5
Anemia and iron deficiency in patients with atrial fibrillation.心房颤动患者的贫血和缺铁。
BMC Cardiovasc Disord. 2022 May 4;22(1):204. doi: 10.1186/s12872-022-02633-6.
6
Glycemic control and atrial fibrillation: an intricate relationship, yet under investigation.血糖控制与心房颤动:复杂的关系,仍在研究中。
Cardiovasc Diabetol. 2022 Mar 14;21(1):39. doi: 10.1186/s12933-022-01473-0.
7
4S-AF scheme and ABC pathway guided management improves outcomes in atrial fibrillation patients.4S-AF 方案和 ABC 通路指导管理可改善房颤患者的结局。
Eur J Clin Invest. 2022 Jun;52(6):e13751. doi: 10.1111/eci.13751. Epub 2022 Feb 1.
8
The Effects of Implementing a Mobile Health-Technology Supported Pathway on Atrial Fibrillation-Related Adverse Events Among Patients With Multimorbidity: The mAFA-II Randomized Clinical Trial.移动医疗技术支持路径对合并多种疾病患者心房颤动相关不良事件的影响:mAFA-II 随机临床试验。
JAMA Netw Open. 2021 Dec 1;4(12):e2140071. doi: 10.1001/jamanetworkopen.2021.40071.
9
Comparative Effectiveness of Early Rhythm Control Versus Rate Control for Cardiovascular Outcomes in Patients With Atrial Fibrillation.早期节律控制与心率控制对房颤患者心血管结局的比较效果。
J Am Heart Assoc. 2021 Dec 21;10(24):e023055. doi: 10.1161/JAHA.121.023055. Epub 2021 Dec 10.
10
Atrial Fibrillation in Patients With Cardiomyopathy: Prevalence and Clinical Outcomes From Real-World Data.心肌病患者心房颤动:真实世界数据的患病率和临床结局。
J Am Heart Assoc. 2021 Dec 7;10(23):e021970. doi: 10.1161/JAHA.121.021970. Epub 2021 Nov 15.